Cancer drug trial success
The successful results of a University of Liverpool led drug trial aimed at developing new therapeutic approaches to cancer have been presented at two American medical conferences.
Jun 6, 2016
Archive: 06/06/2016
Pembrolizumab elicits significant antitumor activity in head and neck cancer patients
Treating head and neck cancer patients with recurrent or metastatic disease with the PD-1 inhibitor pembrolizumab resulted in significant clinical responses in a fifth of the patients from a phase II clinical trial, researchers ...
Jun 6, 2016
Immunotherapy improves survival, quality of life in rapidly progressing head and neck cancer
Immunotherapy doubles overall survival and improves quality of life, with fewer side effects, in a treatment-resistant and rapidly progressing form of head and neck carcinoma, reports a large, randomized international trial ...
Jun 6, 2016
A family-based weight management program improved self-perception among obese children
Battling the childhood obesity epidemic is a priority for many researchers, as obesity during adolescence increases the risk of chronic diseases throughout life. Because obese children have lower quality of life and self-esteem, ...
Jun 6, 2016
